May 3, 2010 Issue | Chemical & Engineering News
 
 

Register for C&EN's Inaugural Virtual Symposium Advances in Drug Discovery and Development on Sept 24th

Featuring Keynotes Greg Verdine and Alexander Kamb, as well as others - Registration is free! http://cenm.ag/symposium

 
Copyright © 2010 American Chemical Society
 

May 3, 2010 Issue

Volume 88, Issue 18
8818cover1_bmscxd_opt
May 3, 2010 Issue, Vol. 88 | Iss. 18
In the next year, the expected approval of small molecules targeting hepatitis C will usher in a new era in treatment
By Lisa M. Jarvis
(pp. 12-17)
Features
Government & Policy
Offshore drilling is being used as a political chip in an effort to secure a climate deal (pp. 30-33)
Science & Technology
Long overshadowed by amyloid-β, tau protein is gaining ground as a therapeutic target in alzheimer's disease (pp. 36-39)
Back Issues
 

Cover Story: The Waiting Game

Alternative Interferons
Small molecules aren't the only new drugs in development to treat hepatitis C
Web Exclusive
 

News of the Week

Earnings Jump In First Quarter

Recovery: Return of consumer demand brings chemical results closer to prerecession level
(p.7)

Biotech Alfalfa Ban Questioned

Biotechnology: Supreme Court hears first case involving a genetically modified crop
(p.8)

Breaking Up Biofilms

Microbiology: Amino acids dismantle bacterial communities
(p.8)

Charles River To Acquire WuXi

Contract Services: $1.6 billion deal creates an integrated drug discovery and clinical development services company
(p.9)

New Editor For Organometallics

Publishing: Texas A&M's John Gladysz succeeds journal's founding editor
(p.9)

Academy Elects New Members

Honors: Ninety scientists join the ranks of the National Academy of Sciences
(p.10)

Renewing America Competes Act

Legislation: House committee clears bill to continue investment in science, innovation, and education
(p.10)

Creating Fuel From Water

Sustainable Energy: New materials aim to improve the path to dihydrogen
(p.11)

Eastman Aims To Sell Its Polyester Unit

Plastics: A sale would complete the firm's exit from the PET business
(p.11)
 

Departments

pond

Business

Some small custom chemical companies survive the recession and defy the move offshore
(pp. 26-28)
In the next year, the expected approval of small molecules targeting hepatitis C will usher in a new era in treatment
(pp. 12-17)
When in Cambridge, major drug companies play by Cambridge rules in a quest for breakthroughs
(pp. 20-24)
Researchers gaining exposure to industrial science are encouraged to publish
Web Exclusive
Small molecules aren't the only new drugs in development to treat hepatitis C
Web Exclusive
Concentrates(pp. 18-19)

    ACS News

    Chemists can gear up for the celebration by getting involved in upcoming outreach activities
    (pp. 45-46)
    Chemists abroad can find an ACS community in their own backyard—or they can form their own
    (p.47)
    8818NOTW_biofilm

    Science & Technology

    Long overshadowed by amyloid-β, tau protein is gaining ground as a therapeutic target in alzheimer's disease
    (pp. 36-39)
    Chemical innovations make tasty battlefield meals, ready-to-eat
    (pp. 40-41)
    Fluorine Chemistry: New generation of safer compounds will benefit pharmaceuticals and agrochemicals
    (p.35)

    Career & Employment

    Large-molecule research is a warm spot for chemists in today’s chilly job market
    (pp. 50-52)

    Editor's Page